DPP4 and metabolic dysfunction-associated steatotic liver disease: Consistently, gardenoside-, si-CTCF- and si-DPP4-induced improvements in the NAFLD animal model led to the inhibition of pro-pyroptotic molecules, which corroborated with the observations in the NAFLD cell model.